| UNITED STATES |
| SECURITIES AND EXCHANGE COMMISSION |
| Washington, D.C. 20549 |
| Notice of Effectiveness |
| Effectiveness Date: |
April 15,
2026 |
| Accession Number: |
0001493152-26-016154 |
| Submission Type: |
POS AM |
| CIK: |
0001541157 |
| Company Name: |
Akari Therapeutics Plc |
| File Number: |
333-292930 |
|
